Drug class
Adrenocortical cytotoxic and adrenolytic agent; steroidogenesis inhibitor
Mechanism of action
The precise molecular mechanism is not fully understood. Mitotane has selective cytotoxic and adrenolytic effects on adrenal cortical tissue and suppresses steroid synthesis, including cortisol production. It can alter hepatic drug-metabolising enzymes and steroid-binding proteins.
General use cases
- Treatment of patients with inoperable, functional or nonfunctional adrenocortical carcinoma (ACC) under the US LYSODREN indication; requires specialist monitoring of plasma mitotane levels, adrenal function and toxicity
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
